IMMUNOTHERAPY OF TYPE-I DIABETES-MELLITUS

被引：7

作者：

EISENBARTH, GS

机构：

[1] NEW ENGLAND DEACONESS HOSP, BOSTON, MA 02215 USA

[2] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1985年 / 102卷 / 06期

关键词：

D O I：

10.7326/0003-4819-102-6-846

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：846 / 848

页数：3

共 24 条

[1]

COBB WE, 1980, NEW ENGL J MED, V303, P1065

[2]

DECKERT T, 1979, ACTA MED SCAND, P48

[3]

EISENBARTH GS, 1983, CLIN RES, V31, pA500

[4]

EISENBARTH GS, 1985, TRIANGLE, V23, P111

[5]

ELLIOTT RB, 1981, LANCET, V2, P1

[6] DIFFERENTIAL SENSITIVITY TO BETA-CELL SECRETAGOGUES IN EARLY, TYPE-I DIABETES-MELLITUS [J].

GANDA, OP ;

SRIKANTA, S ;

BRINK, SJ ;

MORRIS, MA ;

GLEASON, RE ;

SOELDNER, JS ;

EISENBARTH, GS .

DIABETES, 1984, 33 (06) :516-521

[7]

GANDA OP, 1985, DIABETES

[8]

GORSUCH AN, 1981, LANCET, V2, P1363

[9] CAN FUTURE TYPE-1 DIABETES BE PREDICTED QUESTIONABLE - A STUDY IN FAMILIES OF AFFECTED CHILDREN [J].

GORSUCH, AN ;

SPENCER, KM ;

LISTER, J ;

WOLF, E ;

BOTTAZZO, GF ;

CUDWORTH, AG .

DIABETES, 1982, 31 (10) :862-866

[10]

IRVINE WJ, 1980, IMMUNOLOGY DIABETES, P117

← 1 2 3 →